Vicarious Surgical (NYSE:RBOT) Cut to “Sell” at Wall Street Zen

Wall Street Zen downgraded shares of Vicarious Surgical (NYSE:RBOT) from a hold rating to a sell rating in a research note issued to investors on Saturday.

RBOT has been the topic of several other research reports. BTIG Research reaffirmed a “neutral” rating on shares of Vicarious Surgical in a report on Friday, December 12th. Weiss Ratings restated a “sell (e+)” rating on shares of Vicarious Surgical in a research report on Wednesday, January 21st. Two investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Reduce” and a consensus target price of $7.00.

Vicarious Surgical Trading Up 74.1%

Shares of NYSE RBOT opened at $0.47 on Friday. The stock has a market cap of $3.08 million, a price-to-earnings ratio of -0.05 and a beta of 1.53. Vicarious Surgical has a 52 week low of $0.27 and a 52 week high of $13.75. The company’s 50-day moving average price is $2.12 and its 200 day moving average price is $3.76.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in RBOT. Armistice Capital LLC acquired a new stake in shares of Vicarious Surgical during the 4th quarter worth about $1,314,000. Jane Street Group LLC purchased a new position in shares of Vicarious Surgical during the 4th quarter worth $98,000. Geode Capital Management LLC boosted its holdings in shares of Vicarious Surgical by 26.0% during the fourth quarter. Geode Capital Management LLC now owns 40,494 shares of the company’s stock worth $88,000 after purchasing an additional 8,344 shares during the last quarter. Connective Capital Management LLC acquired a new stake in shares of Vicarious Surgical during the third quarter worth $169,000. Finally, Dimensional Fund Advisors LP grew its position in shares of Vicarious Surgical by 22.1% in the third quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock valued at $110,000 after purchasing an additional 3,615 shares during the period. 47.27% of the stock is currently owned by hedge funds and other institutional investors.

About Vicarious Surgical

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.